This AI Stock Plunged 83% but Wall Street Expects a 133% Return in 2024
Is it too late for investors to jump on the artificial intelligence bandwagon? There may still be opportunities, like this medical diagnostics company.
Is it too late for investors to jump on the artificial intelligence bandwagon? There may still be opportunities, like this medical diagnostics company.
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be…
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson, Kenvue and Medtronic.
These five outstanding companies, including a real estate investment trust and a big-box retailer, not only are Wall Street favorites but are expected to boost their dividends this week. That makes them…
Monday's top analyst upgrades and downgrades included Ally Financial, Arbor Realty Trust, Azek, Chesapeake Energy, C3.ai, Endeavor, First Solar, Kingsoft Cloud, Kite Realty, Medtronic and Opendoor Technologies.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic Group, Invesco, Lululemon Athletica, Macy’s, Marathon Petroleum, Medtronic,…
Here are the top analysts calls for Friday, November 25.
Before markets open on Tuesday, these three companies are on deck to report quarterly results.
Wednesday’s additional top analyst upgrades and downgrades were on Home Depot, Intel, Lincoln National, Marvell Technology, Medtronic, Microchip Technology, Nvidia, NXP Semiconductors, ON Semiconductor and more.
Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and Walgreens Boots Alliance.
Wednesday's top analyst upgrades and downgrades included APA, Edwards Lifesciences, Enterprise Products Partners, Global Payments, International Paper, Johnson & Johnson, Match, Medtronic, Netflix, Trade Desk, UDR and Walmart.
Friday's top analyst upgrades and downgrades included Altice USA, Apple, Colgate-Palmolive, Marathon Petroleum, Mastercard, Medtronic, Meta Platforms, Nike, Prologis, Realty Income, SLM, Tenaris and Visa.
Thursday's top analyst upgrades and downgrades included Boston Scientific, Caesars Entertainment, DraftKings, Fiserv, IBM, Medtronic, Norwegian Cruise Line, Pioneer Natural Resources and Raytheon Technologies.
Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags Entertainment, Tellurian and Unity Software.